Company: EHSI
Filing Date: 2025-09-02
Form Type: PRE 14A
Source: 0001437749-25-028137
Chunk: 48

Company: Elite Health Systems Inc.
Filing Date: 2025-09-02
Form: PRE 14A
Chunk 48
---
 |   |     | $ |    (13 | ) |     | $ | (2,110 | ) |

| (1) | The charge recorded in fiscal year 2025 represents a reduction in a deferred tax asset to reflect a change in control limitation as well as adjustments for bad debt and adjustments to the valuation of an investment. |

<div align='center'>27

THE ACQUISITION AGREEMENT</div>

The following is a summary of the material provisions of the Acquisition Agreement but does not purport to describe all of the terms of the Acquisition Agreement. The following summary is qualified in its entirety by reference to the complete text of the Acquisition Agreement, a copy of which is attached as AnnexA to this proxy statement and is incorporated by reference into this proxy statement. Terms used in this proxy statement, unless otherwise defined, have the meanings ascribed to them in the Acquisition Agreement. This summary may not contain all of the information about the Acquisition Agreement that is important to you. We encourage you to read the Acquisition Agreement carefully and in its entirety, as it is the legal document governing the acquisition.

EXPLANATORY NOTE REGARDING THE ACQUISITIONAGREEMENT

The AcquisitionAgreement has been included as Annex A to provide you with information regarding its terms, and we recommend that you read it carefully and in its entirety. The AcquisitionAgreement is a contractual document that is intended to govern the contractual rights and relationships, and to allocate risks, among the Company and Dr. Prasad Anjaneya Jeereddi, our Chief Executive Officer, and his daughter, Dr. Praveena Jeereddi (collectively, the “Selling Stockholders”).

The AcquisitionAgreement contains representations and warranties made by the Selling Stockholders, on the one hand, and the Company, on the other hand, that are qualified in several important respects, which you should consider as you read them in the AcquisitionAgreement. The representations, warranties and covenants of the parties are qualified by the confidential disclosure schedules provided by the Company in connection with the signing of the AcquisitionAgreement on August __, 2025. The disclosure schedules contain information that modifies, qualifies and creates exceptions to the representations and warranties of the Sellers set forth in the AcquisitionAgreement.

In addition, certain of the representations and warranties made by the Selling Stockholders, on the one hand, and the Company , on the other hand, were made as of a specified date, and may have been used for the purpose of allocating risk between the parties to the